Vote Scores
Filings read through

How funds voted at ImmunoGen, Inc.

Filers reporting
432, year to 30 June 2024
Latest meeting on file
Meetings on file
1

In the year to 30 June 2024, 432 filers on Form N-PX reported votes at ImmunoGen, Inc.. The votes fall in one meeting. The figures count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting. Filers gave 653 marks to the ballot items, each with or against management. 51.9% of the marks are with management.

On say-on-pay, 295 of the 396 reporting filers that marked the item voted against management. This is 74.5% of the filers. Of the reported shares, 99.5% went against management. The median of the 3,781 companies on this site with a say-on-pay item is 7.5% of filers and 2.9% of reported shares.

At the meeting of 31 Jan 2024, 3 fund families have a say-on-pay position with management and 43 have a position against management.

By filers reporting in the year to 30 June 2024, ImmunoGen, Inc. was number 1,174 of 11,775 companies with a page and votes in that year. In all seasons on file, category DIRECTOR ELECTIONS is 0.0% of the vote records at ImmunoGen, Inc.. At all companies on this site, it is 52.2%.

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2024. Filings read through . How the figures are made

Since the last update

The site has recorded no change in the tracked figures of this page.

Tracked: the meetings on file and the date of the latest meeting. All recorded changes

The ballot of 31 Jan 2024

431 filers reported votes at this meeting in the year to 30 June 2024. The items are in ballot order: the company's items first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting. The meeting page has the split by reported shares and a CSV file.

  1. Item 1: Advisory vote on executive pay (say-on-pay)

    601 vote records from 415 filers. 295 of the 396 filers that marked the item voted against management. 19 filers gave no management mark.

    2 filers reported share counts too large for the holding. The share split leaves those figures out; the counts of filers keep them. The rule

    • Positions of 46 fund families
    • For 3
    • Against 40
    • Abstain or withhold 3
    • Against management 43
  2. Item 2: Advisory vote on pay tied to a merger or sale

    10 vote records from 9 filers. 4 of the 9 filers that marked the item voted against management.

    • Positions of one fund family
    • Against 1
    • Against management 1
  3. Item 3: EXTRAORDINARY TRANSACTIONS: management items

    The company's items in this category are shown together, because filers word and number them differently.

    216 vote records from 112 filers. 1 of the 112 filers that marked the item voted against management.

    • Positions of 39 fund families
    • For 38
    • Abstain or withhold 1
    • Against management 1
  4. Item 4: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    292 vote records from 136 filers. 14 of the 136 filers that marked the item voted against management.

    • Positions of 42 fund families
    • For 35
    • Against 6
    • Abstain or withhold 1
    • Against management 7

Positions of the fund families at the meeting of 31 Jan 2024

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at ImmunoGen, Inc., meeting of 31 Jan 2024Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund familySay-on-payMerger pay
AllianceBernsteinAgainst, against managementNo report
American CenturyAgainst, against managementNo report
Artisan PartnersAgainst, against managementNo report
BairdAgainst, against managementNo report
BlackRock and iSharesAgainst, against managementNo report
BNY MellonAgainst, against managementNo report
Brighthouse FundsAgainst, against managementNo report
Charles SchwabAgainst, against managementNo report
Columbia ThreadneedleAgainst, against managementNo report
DimensionalAgainst, against managementNo report
DWSAgainst, against managementNo report
EquitableAgainst, against managementNo report
FidelityAgainst, against managementNo report
First TrustAgainst, against managementNo report
Franklin TempletonAbstain, against managementNo report
Global XAgainst, against managementNo report
Goldman SachsAgainst, against managementNo report
Guggenheim and RydexAgainst, against managementNo report
Hartford FundsAgainst, against managementNo report
InvescoAgainst, against managementNo report
J.P. MorganAgainst, against managementAgainst, against management
Jackson National fundsAgainst, against managementNo report
Janus HendersonAbstain, against managementNo report
John Hancock and ManulifeAgainst, against managementNo report
Lincoln FinancialAgainst, against managementNo report
Lord AbbettAgainst, against managementNo report
MassMutualAgainst, against managementNo report
Morgan Stanley, Eaton Vance and CalvertAgainst, against managementNo report
NationwideAgainst, against managementNo report
Natixis and Loomis SaylesAgainst, against managementNo report
Neuberger BermanForNo report
Northern Trust and FlexSharesAgainst, against managementNo report
Nuveen and TIAAAgainst, against managementNo report
Pacific Life fundsAgainst, against managementNo report
PGIM and PrudentialForNo report
PIMCOAgainst, against managementNo report
PrincipalAgainst, against managementNo report
ProShares and ProFundsAgainst, against managementNo report
SEIAgainst, against managementNo report
State Street and SPDRAgainst, against managementNo report
T. Rowe PriceAgainst, against managementNo report
TransamericaAgainst, against managementNo report
VanguardAgainst, against managementNo report
Victory CapitalAgainst, against managementNo report
VirtusForNo report
VoyaAbstain, against managementNo report

Every meeting on file

Meetings of ImmunoGen, Inc., from Form N-PX filings, newest firstA meeting with 20 or more reporting filers has its own page. Dates up to three days apart count as one meeting.
MeetingSeasonFilers reportingItemsFilers against management on say-on-pay
year to 30 June 2024431474.5%

Say-on-pay, season by season

Say-on-pay at ImmunoGen, Inc.: filers reporting on Form N-PXThe share of filers, and of the shares they reported, that voted against management.
SeasonFilers reportingFilers against managementReported shares against management
year to 30 June 202443274.5%99.5%
ImmunoGen, Inc. and the median of companies on this site, year to 30 June 2024
Say-on-payThis companyMedian of companies on this site
Filers against management74.5%7.5%
Reported shares against management99.5%2.9%

The median covers 3,781 companies. Each has a say-on-pay item that 20 or more filers reported. The two figures are not a grade. The median is a reference only.

Vote records at ImmunoGen, Inc. by category, every seasonThe category is the one each filer chose.
CategoryVote recordsShare
SECTION 14A SAY-ON-PAY VOTES61154.6%
EXTRAORDINARY TRANSACTIONS21619.3%
CORPORATE GOVERNANCE29226.1%

The record at the SEC

Each link loaded on .

Cite this page

Vote Scores. How funds voted at ImmunoGen, Inc.. https://votescores.com/company/immunogen-inc/. Source: SEC EDGAR, Form N-PX and N-PX/A filings read through .

Questions

How many meetings of ImmunoGen, Inc. are on file?
1 meeting is on file, on 31 Jan 2024. 1 meeting has 20 or more reporting filers and has its own page.
Did filers report proposals from security holders at ImmunoGen, Inc.?
Not enough filers reported a proposal from security holders for the site to show one in the year to 30 June 2024. The ballot shows the items that filers did report.
Is this the meeting result?
No. The figures count the filers that report on Form N-PX and the shares they reported. Other holders are not in the count. ImmunoGen, Inc. reports the result of a vote on Form 8-K.
How does the site group meetings and names?
Filers type company names and meeting dates themselves. The site groups spellings of one company name. It treats meeting dates up to three days apart as one meeting. The data runs through 13 Nov 2026.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list ImmunoGen, Inc., grouped by company. The name is the most common spelling among filers. The filers wrote the filings. Filings read through .